What is Pacific Diabetes Technologies?
Pacific Diabetes Technologies, based in Portland, Oregon, is dedicated to simplifying diabetes management through its innovative SynerG device. This integrated system combines continuous glucose monitoring with insulin delivery management, specifically targeting insulin users. The company's core mission is to enhance the quality of life for individuals managing diabetes by offering a unified device that streamlines daily care routines. By addressing common caregiver frustrations and leveraging scientific innovation, Pacific Diabetes Technologies aims to significantly improve health outcomes for millions worldwide.
How much funding has Pacific Diabetes Technologies raised?
Pacific Diabetes Technologies has raised a total of $3M across 2 funding rounds:
Debt
$59K
Debt
$2.9M
Debt (2021): $59K with participation from PPP
Debt (2025): $2.9M, investors not publicly disclosed
Key Investors in Pacific Diabetes Technologies
PPP
Public-Private Partnership
What's next for Pacific Diabetes Technologies?
The substantial enterprise-level funding positions Pacific Diabetes Technologies for accelerated growth and market expansion. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden the company's commercial reach. The strategic nature of the recent investment suggests a focus on scaling operations and solidifying its market presence in the competitive diabetes technology sector. Future developments will likely center on refining the SynerG device and potentially exploring new product lines to further support individuals with diabetes and their caregivers.
See full Pacific Diabetes Technologies company page
